{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T22:50:39Z","timestamp":1754261439901},"reference-count":13,"publisher":"Pharmaceutical Society of Japan","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2022,9,1]]},"DOI":"10.1248\/bpb.b22-00170","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T22:10:31Z","timestamp":1661983831000},"page":"1254-1258","source":"Crossref","is-referenced-by-count":6,"title":["Classification of Skin Injury Risk Caused by Extravasation of Electrolyte Solutions or Infusions in a Rat Model"],"prefix":"10.1248","volume":"45","author":[{"given":"Takanori","family":"Taogoshi","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Services, Hiroshima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuuka","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, Hiroshima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Uno","sequence":"additional","affiliation":[{"name":"School of Pharmaceutical Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoharu","family":"Yokooji","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, Graduate School of Biomedical and Health Sciences, Hiroshima University"},{"name":"Department of Frontier Science for Pharmacotherapy, Graduate School of Biomedical and Health Sciences, Hiroshima University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hiroshima Prefectural Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Hide","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Hiroshima City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Services, Hiroshima University Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Dorr RT. Antidotes to vesicant chemotherapy extravasations. <i>Blood Rev.<\/i>, <b>4<\/b>, 41\u201360 (1990).","DOI":"10.1016\/0268-960X(90)90015-K"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Sauerland C, Engelking C, Wickham R, Corbi D. Vesicant extravasation part I: Mechanisms, pathogenesis, and nursing care to reduce risk. <i>Oncol. Nurs. Forum<\/i>, <b>33<\/b>, 1134\u20131141 (2006).","DOI":"10.1188\/06.ONF.1134-1141"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) P\u00e9rez Fidalgo JA, Garc\u00eda Fabregat L, Cervantes A, Margulies A, Vidall C, Roila F. Management of chemotherapy extravasation: ESMO\u2013EONS clinical practice guidelines. <i>Eur. J. Oncol. Nurs.<\/i>, <b>16<\/b>, 528\u2013534 (2012).","DOI":"10.1016\/j.ejon.2012.09.004"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Gorski LA, Stranz M, Cook LS, Joseph JM, Kokotis K, Sabatino-Holmes P, Van Gosen L. Development of an evidence-based list of noncytotoxic vesicant medications and solutions. <i>J. Infus. Nurs.<\/i>, <b>40<\/b>, 26\u201340 (2017).","DOI":"10.1097\/NAN.0000000000000202"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Shibata Y, Yokooji T, Itamura R, Sagara Y, Taogoshi T, Ogawa K, Tanaka M, Hide M, Kihira K, Matsuo H. Injury due to extravasation of thiopental and propofol: risks\/effects of local cooling\/warming in rats. <i>Biochem. Biophys. Rep.<\/i>, <b>8<\/b>, 207\u2013211 (2016).","DOI":"10.1016\/j.bbrep.2016.09.005"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Shibata Y, Sagara Y, Yokooji T, Taogoshi T, Tanaka M, Hide M, Matsuo H. Evaluation of risk of injury by extravasation of hyperosmolar and vasopressor agents in a rat model. <i>Biol. Pharm. Bull.<\/i>, <b>41<\/b>, 951\u2013956 (2018).","DOI":"10.1248\/bpb.b18-00105"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Le A, Patel S. Extravasation of noncytotoxic drugs: a review of the literature. <i>Ann. Pharmacother.<\/i>, <b>48<\/b>, 870\u2013886 (2014).","DOI":"10.1177\/1060028014527820"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Reynolds PM, Maclaren R, Mueller SW, Fish DN, Kiser TH. Management of extravasation injuries: a focused evaluation of noncytotoxic medications. <i>Pharmacotherapy<\/i>, <b>34<\/b>, 617\u2013632 (2014).","DOI":"10.1002\/phar.1396"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Dorr RT, Snead K, Liddil JD. Skin ulceration potential of paclitaxel in a mouse skin model <i>in vivo.<\/i> <i>Cancer<\/i>, <b>78<\/b>, 152\u2013156 (1996).","DOI":"10.1002\/(SICI)1097-0142(19960701)78:1<152::AID-CNCR21>3.0.CO;2-Y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Upton J, Mulliken JB, Murray JE. Major intravenous extravasation injuries. <i>Am. J. Surg.<\/i>, <b>137<\/b>, 497\u2013506 (1979).","DOI":"10.1016\/0002-9610(79)90121-1"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Behnia R, Wilkinson CJ. Lidocaine treatment of experimental cutaneous lesions from potassium chloride injection. <i>Anesthesiology<\/i>, <b>47<\/b>, 428\u2013429 (1977).","DOI":"10.1097\/00000542-197711000-00007"},{"key":"12","unstructured":"12) Heckler FR, McCraw JB. Calcium-related cutaneous necrosis. <i>Surg. Forum<\/i>, <b>27<\/b>, 553\u2013555 (1976)."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Gruber RP, Laub DR, Vistnes LM. The effect of hydrotherapy on the clinical course and pH of experimental cutaneous chemical burns. <i>Plast. Reconstr. Surg.<\/i>, <b>55<\/b>, 200\u2013204 (1975).","DOI":"10.1097\/00006534-197502000-00011"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/45\/9\/45_b22-00170\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:30:39Z","timestamp":1715232639000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/45\/9\/45_b22-00170\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,1]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b22-00170","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,1]]},"article-number":"b22-00170"}}